Bioporto Overview

  • Year Founded
  • 1917

Year Founded

  • Status
  • Public

  • Employees
  • 38

Employees

  • Stock Symbol
  • BIOPOR

Stock Symbol

  • Share Price
  • $0.23
  • (As of Friday Closing)

Bioporto General Information

Description

Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Contact Information

Website
www.bioporto.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Tuborg Havnevej 15 Street
  • 2900 Hellerup
  • Denmark
+45 45
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
CSE
Corporate Office
  • Tuborg Havnevej 15 Street
  • 2900 Hellerup
  • Denmark
+45 45

Bioporto Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioporto Stock Performance

As of 25-Apr-2025, Bioporto’s stock price is $0.23. Its current market cap is $98.8M with 430M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.23 $0.22 $0.17 - $0.41 $98.8M 430M 308K -$0.02

Bioporto Financials Summary

As of 31-Dec-2024, Bioporto has a trailing 12-month revenue of $5.26M.

In Thousands,
USD 		TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 82,172 82,172 108,597 99,598
Revenue 5,257 5,257 4,493 4,094
EBITDA (10,524) (10,524) (8,562) (10,817)
Net Income (9,899) (9,899) (8,174) (10,731)
Total Assets 13,395 13,395 13,334 15,636
Total Debt 1,561 1,561 1,076 1,532
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bioporto Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bioporto‘s full profile, request access.

Request a free trial

Bioporto Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research se
Biotechnology
Hellerup, Denmark
38 As of 2024

Austin, TX
 

Turku, Finland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bioporto Competitors (3)

One of Bioporto’s 3 competitors is Luminex, a Corporate Backed or Acquired company based in Austin, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Luminex Corporate Backed or Acquired Austin, TX
HyTest Formerly PE-Backed Turku, Finland
Creative Diagnostics Corporation Shirley, NY
You’re viewing 3 of 3 competitors. Get the full list »

Bioporto Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Bioporto ESG

Risk Overview

Risk Rating

Updated December, 13, 2023

27.89 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,048

Rank

Percentile

Pharmaceuticals

Industry

of 914

Rank

Percentile

Biotechnology

Subindustry

of 404

Rank

Percentile

To view Bioporto’s complete esg history, request access »

Bioporto FAQs

  • When was Bioporto founded?

    Bioporto was founded in 1917.

  • Where is Bioporto headquartered?

    Bioporto is headquartered in Hellerup, Denmark.

  • What is the size of Bioporto?

    Bioporto has 38 total employees.

  • What industry is Bioporto in?

    Bioporto’s primary industry is Biotechnology.

  • Is Bioporto a private or public company?

    Bioporto is a Public company.

  • What is Bioporto’s stock symbol?

    The ticker symbol for Bioporto is BIOPOR.

  • What is the current stock price of Bioporto?

    As of 25-Apr-2025 the stock price of Bioporto is $0.23.

  • What is the current market cap of Bioporto?

    The current market capitalization of Bioporto is $98.8M.

  • What is Bioporto’s current revenue?

    The trailing twelve month revenue for Bioporto is $5.26M.

  • Who are Bioporto’s competitors?

    Luminex, HyTest, and Creative Diagnostics are competitors of Bioporto.

  • What is Bioporto’s annual earnings per share (EPS)?

    Bioporto’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »